-
公开(公告)号:US20180230227A1
公开(公告)日:2018-08-16
申请号:US15951082
申请日:2018-04-11
Applicant: Genentech, Inc.
Inventor: Changchun DU , Jeong KIM , Jing ZHU , Jack BEVERS, III , Kevin WALSH , Patricia DE ALMEIDA , James ANDYA , Ye SHEN
Abstract: The invention provides anti-OX40 antibodies and methods of using the same.
-
公开(公告)号:US20210009705A1
公开(公告)日:2021-01-14
申请号:US16911229
申请日:2020-06-24
Applicant: Genentech, Inc.
Inventor: Changchun DU , Jeong KIM , Jing ZHU , Jack BEVERS, III , Kevin WALSH , Patricia DE ALMEIDA , James ANDYA , Ye SHEN
Abstract: The invention provides anti-OX40 antibodies and methods of using the same.
-
3.COMBINATION THERAPY COMPRISING ANTI-ANGIOGENESIS AGENTS AND OX40 BINDING AGONISTS 审中-公开
Title translation: 包含抗血管发生剂和OX40结合激素的联合治疗公开(公告)号:US20170015755A1
公开(公告)日:2017-01-19
申请号:US15280586
申请日:2016-09-29
Applicant: Genentech, Inc.
Inventor: Kevin WALSH , Patricia DE ALMEIDA , Changchun DU , Jeong KIM , Jing ZHU , Jack BEVERS, III , James ANDYA , Ye SHEN
CPC classification number: C07K16/2878 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K47/6803 , A61K47/6849 , A61K48/00 , A61K2039/505 , A61K2039/507 , C07K16/22 , C07K16/30 , C07K16/3015 , C07K16/3023 , C07K16/303 , C07K16/3038 , C07K16/3046 , C07K16/3069 , C07K2317/21 , C07K2317/24 , C07K2317/51 , C07K2317/515 , C07K2317/56 , C07K2317/71 , C07K2317/732 , C07K2317/75 , C07K2317/76 , C07K2317/92
Abstract: The invention provides compositions and methods for treating cancers. The method comprises administering an anti-angiogenesis agent and an OX40 binding agonist.
Abstract translation: 本发明提供了治疗癌症的组合物和方法。 该方法包括施用抗血管发生剂和OX40结合激动剂。
-
-